Agenus Inc / Stock Price
13.62 +1.27 (10.28%)
After hours: 13.88 +0.26 (1.88%)
AGEN(NASDAQ)
May 24, 4:00 PM EDT · Currency in USD · Disclaimer
Agenus Inc., a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally.
People also ask
Is AGEN a good stock to buy?
What is the prediction for AGEN stock in 2025?
What is the Nasdaq forecast for AGEN?
Who owns AGEN stock?
AGEN | Complete Agenus Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Our mission is to the power of the immune system to bring affordable, curative therapies to cancer patients.
People also search for
Discover real-time Agenus Inc. Common Stock (AGEN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions.
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its ...
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases.
Get Agenus Inc (AGEN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
See the latest Agenus Inc stock price (AGEN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Complete Agenus Inc. stock information by Barron's. View real-time AGEN stock price and news, along with industry-best analysis.